CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia
==========

CS MEDICA announces the approval of CANNASEN® Protective Nasal Gel in Malaysia, marking a breakthrough in overcoming regulatory barriers in Asia. The CEO, Lone Henriksen, expresses the significance of this achievement and the potential for future opportunities in Asia. CS MEDICA plans to expand its product range throughout Asia, leveraging the insights gained and strategies developed through this process. The Protective Nasal Gel, CANNASEN®, offers a natural solution for preventing allergies, hay fever, and viral infections by forming a protective barrier over the nasal mucous membranes. CS MEDICA is a Danish-based MedTech company focused on creating over-the-counter treatments for autoimmune and stress-related diseases. They are listed on the Spotlight Stock Market in Stockholm.



https://www.tradingview.com/news/reuters.com,2024-04-04:newsml_Wkr6FNzYC:0-cs-medica-a-s-breaks-through-asian-market-barrier-with-approval-of-protective-nasal-gel-in-malaysia/